Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai: Our ...

TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa: Our Bureau, Mumbai ...

Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma: Paris Friday, January 10, 2025, 15:00 Hrs [IST] Res ...

Responding to the draft notification issued by the union health ministry last Saturday, the chairman of the Confederation of Indian Pharmaceutical Industries (CIPI), R K Jain, has commented that the ...

The Central Drugs Standard Control Organisation (CDSCO) and Indian Council of Medical Research (ICMR) have together released the draft standard evaluation protocols for the purpose of issuing license ...

The Union ministry of commerce & industry has issued a notification introducing amendments to the Foreign Trade Policy (FTP) 2023, aimed at fostering enhanced stakeholder engagement. The notification, ...

The Karnataka Pharma Retailers & Distributors Organization (KPRDO) has urged the Union health ministry for reimbursement for cut strips of expiry dated medicines. In a communication to the Ministry ...

Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that it has acquired Galzin (zinc acetate). “This ...

Indian pharmaceutical companies are operating in a highly regulated environment, with rules and compliance standards often being prescriptive. While these regulations are essential to ensure quality, ...

The Indian Council of Medical Research's (ICMR) National Institute for Research in Digital Health and Data Science (NIRDHDS) will host a two-day workshop on “Unlocking AI for Healthcare: A Beginner’s ...

IceCure Medical Ltd., a developer of minimally-invasive cryoablation technology that destroys tumours by freezing as an alternative to surgical tumour removal, announced it has received an Intention ...

GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...